Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.
作者信息
Netto Georges J, Saad Rana
机构信息
Department of Pathology, Baylor University Medical Center, Dallas, Texas, USA.
出版信息
Proc (Bayl Univ Med Cent). 2005 Jan;18(1):7-12. doi: 10.1080/08998280.2005.11928025.
Abstract
摘要
相似文献
1
Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.诊断分子病理学，第2部分：蛋白质组学及分子诊断在血液病理学中的临床应用
Proc (Bayl Univ Med Cent). 2005 Jan;18(1):7-12. doi: 10.1080/08998280.2005.11928025.
2
Recommended curriculum for teaching hematopathology to subspecialty hematopathology fellows.向血液病理学亚专业进修医生讲授血液病理学的推荐课程。
Am J Clin Pathol. 2007 Jun;127(6):962-76. doi: 10.1309/6C41Q30M5RM83QMH.
3
Pitfalls in diagnostic hematopathology: part I.诊断血液病理学中的陷阱：第一部分。
Int J Clin Exp Pathol. 2009;2(1):11-20. Epub 2008 Apr 21.
4
Five important advances in hematopathology.血液病理学的 5 大重要进展。
Arch Pathol Lab Med. 2014 Mar;138(3):410-9. doi: 10.5858/ARPA.2012-0645-RA.
5
Molecular diagnostics.分子诊断学
Hematology Am Soc Hematol Educ Program. 2003:279-93. doi: 10.1182/asheducation-2003.1.279.
6
New transcription factors in diagnostic hematopathology.诊断血液病理学中的新转录因子。
Adv Anat Pathol. 2007 Jan;14(1):25-35. doi: 10.1097/PAP.0b013e31802f0495.
7
Artificial Intelligence and Digital Microscopy Applications in Diagnostic Hematopathology.人工智能与数字显微镜在血液病理学诊断中的应用
Cancers (Basel). 2020 Mar 26;12(4):797. doi: 10.3390/cancers12040797.
8
Gold and silver nanoparticles for clinical diagnostics - From genomics to proteomics.金纳米颗粒和银纳米颗粒在临床诊断中的应用——从基因组学到蛋白质组学。
J Proteomics. 2012 Jun 6;75(10):2811-23. doi: 10.1016/j.jprot.2011.11.007. Epub 2011 Nov 17.
9
Challenges in Consolidated Reporting of Hematopoietic Neoplasms.造血系统肿瘤合并报告中的挑战。
Surg Pathol Clin. 2013 Dec;6(4):795-806. doi: 10.1016/j.path.2013.08.001. Epub 2013 Oct 18.
10
Molecular and Cytogenetic Education in Hematopathology Fellowship.血液病理学研究员培训中的分子和细胞遗传学教育。
Am J Clin Pathol. 2019 Sep 9;152(4):438-445. doi: 10.1093/ajcp/aqz048.
引用本文的文献
1
Cell-blocks and other ancillary studies (including molecular genetic tests and proteomics).细胞块及其他辅助研究（包括分子遗传学检测和蛋白质组学）。
Cytojournal. 2021 Feb 22;18:4. doi: 10.25259/Cytojournal_3_2021. eCollection 2021.
2
Pseudo-HE images derived from CARS/TPEF/SHG multimodal imaging in combination with Raman-spectroscopy as a pathological screening tool.源自CARS/TPEF/SHG多模态成像并结合拉曼光谱的伪苏木精-伊红（HE）图像作为一种病理筛查工具。
BMC Cancer. 2016 Jul 26;16:534. doi: 10.1186/s12885-016-2520-x.
本文引用的文献
1
All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia.全反式维甲酸和蒽环类药物单药化疗治疗老年急性早幼粒细胞白血病患者
Blood. 2004 Dec 1;104(12):3490-3. doi: 10.1182/blood-2004-04-1642. Epub 2004 Aug 3.
2
Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.荧光原位杂交技术在1例急性髓系白血病M4 Eo病例中鉴定出被del(16)(q22)掩盖的隐匿性t(16;16)(p13;q22) 。
J Mol Diagn. 2004 Aug;6(3):271-4. doi: 10.1016/S1525-1578(10)60521-1.
3
Tyrosine kinase inhibitors in cancer therapy.癌症治疗中的酪氨酸激酶抑制剂。
Clin Biochem. 2004 Jul;37(7):618-35. doi: 10.1016/j.clinbiochem.2004.05.006.
4
Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后嵌合体诊断的策略及临床意义
Acta Haematol. 2004;112(1-2):16-23. doi: 10.1159/000077555.
5
Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers.异基因干细胞移植后的诊断性嵌合分析：新方法与标志物
Am J Pharmacogenomics. 2004;4(3):177-87. doi: 10.2165/00129785-200404030-00005.
6
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?混合嵌合体增加是急性淋巴细胞白血病儿童异基因干细胞移植后不良预后的重要预后因素：抢先免疫疗法的可能作用？
J Clin Oncol. 2004 May 1;22(9):1696-705. doi: 10.1200/JCO.2004.05.198.
7
Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry.通过磁珠辅助、自动化样品处理及基质辅助激光解吸电离飞行时间质谱法进行血清肽谱分析。
Anal Chem. 2004 Mar 15;76(6):1560-70. doi: 10.1021/ac0352171.
8
The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL).荧光原位杂交（FISH）在慢性淋巴细胞白血病（CLL）中的应用。
Hematology. 2004 Feb;9(1):11-5. doi: 10.1080/10245330310001652446.
9
A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia chromosome-positive (Ph+/BCR-ABL+) acute lymphoblastic leukemia (ALL) (CSTI571ADE 10).一项随机、多中心、开放标签的II期研究，旨在确定伊马替尼（格列卫，原STI571）诱导治疗与标准诱导化疗相比，在年龄大于55岁的费城染色体阳性（Ph+/BCR-ABL+）急性淋巴细胞白血病（ALL）患者中的安全性和疗效（CSTI571ADE 10）。
Ann Hematol. 2003 Nov;82(11):716-20. doi: 10.1007/s00277-003-0728-8. Epub 2003 Aug 28.
10
Pediatric acute lymphoblastic leukemia.小儿急性淋巴细胞白血病
Hematology Am Soc Hematol Educ Program. 2003:102-31. doi: 10.1182/asheducation-2003.1.102.
Zotero 插件